Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): A Disease of Two Genomes

Neurologist

Volumn 10, Issue 1, 2004, Pages 8-17

  Hirano, Michio ^a   Nishigaki, Yutaka ^a   Martí, Ramon ^a  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

Author keywords

Mitochondria; Mitochondrial DNA; Mitochondrial encephalomyopathy; MNGIE

Indexed keywords

CELL NUCLEUS DNA; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; DEOXYURIDINE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); THYMIDINE; THYMIDINE PHOSPHORYLASE; THYMINE; UBIQUINOL CYTOCHROME C REDUCTASE;

ADOLESCENT; ADULT; CHILD; CLINICAL FEATURE; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL RESPIRATION; MNGIE SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; ALDEHYDE-LYASES; BRAIN; CACHEXIA; CHILD; CHILD, PRESCHOOL; DEMENTIA; DEOXYURIDINE; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MITOCHONDRIAL DISEASES; MITOCHONDRIAL ENCEPHALOMYOPATHIES; POINT MUTATION; REPRESSOR PROTEINS; THYMIDINE PHOSPHORYLASE;

EID: 0942297994     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000106919.06469.04     Document Type: Review

References (59)

1. Holt I, Harding A, Morgan-Hughes J. Deletions of mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988;331:34-38.
2. Lestienne P, Ponsot G. Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet. 1988;1:885.
3. Zeviani M, Moraes C, DiMauro S, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology. 1988;38:1339-1346.
4. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242:1427-1430.
5. Schon EA, Hirano M, DiMauro S. Molecular genetic basis of the mitochondrial encephalomyopathies. In: AHV Schapira, S DiMauro, eds. Mitochondrial Disorders in Neurology II. Boston: Butterworth-Heinemann; 2001.
6. Bourgeron T, Rustin P, Chretien D, et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genet. 1995;11:144-149.
7. Hirano M, Silvestri G, Blake DM, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology. 1994;44:721-727.
8. Papadimitriou A, Comi GP, Hadjigeorgiou GM, et al. Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome. Neurology. 1998;51:1086-1092.
9. Okamura K, Santa T, Nagae K, et al. Congenital oculoskeletal myopathy with abnormal muscle and liver mitochondria. J Neurol Sci. 1976;27:79-91.
10. Ionasescu VV. Oculogastrointestinal muscular dystrophy. Am J Med Gen. 1983;15:103-112.
11. Bardosi A, Creutzfeldt W, DiMauro S, et al. Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol (Berl). 1987;74:248-258.
12. Steiner I, Steinberg A, Argov Z, et al. Familial progressive neuronal disease and chronic idiopathic intestinal pseudo-obstruction. Neurology. 1987;37:1046-1050.
13. Simon LT, Horoupian DS, Dorfman LJ, et al. Polyneuropathy, ophthalmoplegia, leukoencephalopathy and intestinal pseudo-obstruction: PO-LIP syndrome. Ann Neurol. 1990;28:349-360.
14. Uncini A, Servidei S, Silvestri G, et al. Ophthalmoplegia, demyelinating neuropathy, leukoencephalopathy, myopathy, and gastrointestinal dysfunction with multiple deletions of mitochondrial DNA: a mitochondrial multisystem disorder in search of a name. Muscle & Nerve. 1994;17:667-674.
15. Collier TG, Applegarth DA, Calne DB. Mitochondrial neurogastrointestinal encephalomyopathy with multiple deletions of mitochondrial DNA. Ann Neurol. 1996;40:545.
16. Debouverie M, Wagner M, Ducrocq X, et al. MNGIE syndrome in 2 siblings. Rev Neurol (Paris). 1997;153:547-553.
17. Hamano H, Ohta T, Takekawa Y, et al. Mitochondrial neurogastrointestinal encephalomyopathy presenting with protein-losing gastroenteropathy and serum copper deficiency: a case report. Rinsho Shinkeigaku. 1997;10:917-922.
18. Lowsky R, Davidson G, Wolman S, et al. Familial visceral myopathy associated with a mitochondrial myopathy. Gut. 1993;34:279-283.
19. Perez-Atayde AR, Fox V, Teitelbaum JE, et al. Mitochondrial neurogastrointestinal encephalomyopathy. Diagnosis by rectal biopsy. Am J Surg Pathol. 1998;22:1141-1147.
20. Mueller LA, Camilleri M, Emslie-Smith AM. Mitochondrial neurogastrointestinal encephalomyopathy: manometric and diagnostic features. Gastroenterology. 1999;116:959-963.
21. Nishino I, Spinazzola A, Papadimitriou A, et al. MNGIE: An autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol. 2000;47:792-800.
22. Gamez J, Ferreiro C, Accarino ML, et al. Phenotypic variability in a Spanish family with MNGIE. Neurology. 2002;59:455-457.
23. Anuras S, Mitros F, Nowak T, et al. A familial visceral myopathy with external ophthalmoplegia and autosomal recessive transmission. Gastroenterology. 1983;84:346-353.
24. Rowland LP. Progressive external ophthalmoplegia. Handbook Clin. Neurol. 1992:287-329.
25. Li V, Hostein J, Romero NB, et al. Chronic intestinal pseudoobstruction with myopathy and ophthalmoplegia: a muscular biochemical study of a mitochondrial disorder. Dig Dis Sci. 1992;37:456-463.
26. Ban S, Mori N, Saito K, et al. An autopsy case of mitochondrial encephalomyopathy (MELAS) with special reference to extra-neuromuscular abnormalities. Acta Pathol Jpn. 1992;42:818-825.
27. Kuroiwa T, Kuwata T, Nakayama T, et al. Mitochondrial encephalomyopathy showing prominent microvacuolation and necrosis of intestinal smooth muscle cells: a case diagnosed by rectal biopsy. Acta Neuropathol (Berl). 1998;96:86-90.
28. Nicholl JA, Moss TH, Love S, et al. Clinical and autopsy findings in two cases of MELAS presenting with stroke-like episodes but without clinical myopathy. Clin Neuropathol. 1993;12:38-43.
29. Verma A, Piccoli DA, Bonilla E, et al. A novel mitochondrial G8313A mutation associated with prominent initial gastrointestinal symptoms and progressive encephaloneuropathy. Pediatr Res. 1997;42:448-454.
30. Zelnik N, Axelrod FB, Leshinsky E, et al. Mitochondrial encephalomyopathies presenting with features of autonomic and visceral dysfunction. Pediatr Neurol. 1996;14:251-254.
31. Cervera R, Bruix J, Bayes A, et al. Chronic intestinal pseudoobstruction and ophthalmoplegia in a patient with mitochondrial myopathy. Gut. 1988;29:544-547.
32. Carrozzo R, Hirano M, Fromenty B, et al. Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses. Neurology. 1998;50:99-106.
33. Hirano M, Yebenes J, Jones AC, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome maps to chromosome 22q13.32-qter. Am J Hum Genet. 1998;63:526-533.
34. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999;283:689-692.
35. Brown NS, Bicknell R. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J. 1998;334:1-8.
36. Spinazzola A, Marti R, Nishino I, et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem. 2002;277:4128-4133.
37. a. Martí R, Nishigaki Y, Hirano M. Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. Biochem Biophys Res Commun. 2003;303:14-18.
38. Eccleston PA, Funa K, Heldin CH. Neurons of the peripheral nervous system express thymidine phosphorylase. Neurosci Lett. 1995;192:137141.
39. Fox SB, Moghaddam A, Westwood M, et al. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissue: an immunohistochemical study. J Pathol. 1995;176:183-190.
40. Matsukawa K, Moriyama A, Kawai Y, et al. Tissue distribution of human gliostatin/platelet-derived endothelial cell growth factor (PD-ECGF) and its drug-induced expression. Biochim Biophys Acta. 1996;1314:71-82.
41. Waltenberger J, Usuki K, Fellstrom B, et al. Platelet-derived endothelial cell growth factor. Pharmacokinetics, organ distribution and degradation after intmvenous intravenous administration in rats. FEBS Lett. 1992;313:129-132.
42. Yoshimura A, Kuwazuru Y, Furukawa T, et al. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta. 1990;1034:107-113.
43. Bestwick RK, Mathews CK. Unusual compartment of precursors for nuclear and mitochondrial DNA in mouse L cells. J Biol Chem. 1982;257:9305-9308.
44. Bestwick RK, Moffett GL, Mathews CK. Selective expansion of mitochondrial nucleoside triphosphate pools in antimetabolite-treated HeLa cells. J Biol Chem. 1982;257:9300-9304.
45. Bogenhagen D, Clayton DA. Thymidylate nucleotide supply for mitochondrial DNA synthesis in mouse L-cells. J. Biol. Chem. 1976;249:2938-2944.
46. Berk AJ, Clayton DA. A genetically distinct thymidine kinase in mammalian mitochondrial. Exclusive labeling of mitochondrial deoxyribonucleic acid. J Biol Chem. 1973;248:2722-2729.
47. Johansson M, Karlsson A. Cloning of the cDNA and chromosomal localization of the gene for human thymidine kinase 2. J Biol Chem. 1997;13:8454-8458.
48. Saada A, Shaag A, Mandel H, et al. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet. 2001;29:342-344.
49. Mandel H, Szargel R, Labay V, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet. 2001;29:337-341.
50. Rosenberg MJ, Agarwala R, Bouffard G, et al. Mutant deoxynucleotide carrier is associated with congenital microcephaly. Nat Genet. 2002;32:175-179.
51. Kaukonen J, Juselius JK, Tiranti V, et al. Role of adenine nucleotide translocator I in mtDNA maintenance. Science. 2000;289:782-785.
52. Spelbrink JN, Li FY, Tiranti V, et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet. 2001;28:223-231.
53. Washington MT, Rosenberg AH, Griffin K, et al. Biochemical analysis of mutant T7 primase/helicase proteins defective in DNA binding, nucleotide hydrolysis, and the coupling of hydrolysis with DNA unwinding. J Biol Chem. 1996;271:26825-26834.
54. Dalakas MC, Illa I, Pezeshkpour GH, et al. Mitochondrial myopathy caused by long-term zidovudine therapy. New Engl J Med. 1990;322:1098-1105.
55. Arnaudo E, Dalakas MC, Shanske S, et al. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet. 1991;337:508-510.
56. Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nature Med. 1995;1:417-422.
57. Cui L, Toon S, Shininazi RF, et al. Cellular and molecular events leading to mitochondrial toxicity of 1-[2′-deoxy-2′fluoro- β-D-arabinofuranosyl]-5-iodouracil in human liver cells. J Clin Invest. 1995;95:555-563.
58. Brahams D. Deaths in US fialuridine trial. Lancet. 1994;343:1494-1495.
59. Hagiwara K, Stenman G, Honda H, et al. Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene. Mol Cell Biol. 1991;11:2125-2132.